These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6341127)

  • 1. Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose.
    Madsbad S; Kehlet H; Hilsted J; Tronier B
    Diabetes; 1983 May; 32(5):436-8. PubMed ID: 6341127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion.
    Hampton SM; Morgan LM; Tredger JA; Cramb R; Marks V
    Diabetes; 1986 May; 35(5):612-6. PubMed ID: 3514335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
    Nauck MA; Homberger E; Siegel EG; Allen RC; Eaton RP; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1986 Aug; 63(2):492-8. PubMed ID: 3522621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glucose decreases hepatic extraction of insulin.
    Gibby OM; Hales CN
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):921-3. PubMed ID: 6403135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients.
    Dupré J; Behme MT; Hramiak IM; Longo CJ
    Metabolism; 1993 Aug; 42(8):921-7. PubMed ID: 8345813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
    Nauck M; Stöckmann F; Ebert R; Creutzfeldt W
    Diabetologia; 1986 Jan; 29(1):46-52. PubMed ID: 3514343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of human C-peptide in man.
    Faber OK; Kehlet H; Madsbad S; Binder C
    Diabetes; 1978; 27 Suppl 1():207-9. PubMed ID: 631443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of plasma insulin C-peptide and proinsulin-like components to glucose and glucagon in the pig.
    Kobayashi K
    Endocrinol Jpn; 1975 Dec; 22(6):489-96. PubMed ID: 1231990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.
    Turner RC; Heding LG
    Diabetologia; 1977 Dec; 13(6):571-7. PubMed ID: 201531
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of ranitidine infusion on glucose, insulin and C-peptide serum levels induced by oral glucose tolerance test in healthy subjects.
    Gentile S; Marmo R; Costume A; Orlando C; D'Alessandro R; De Bellis G; Porcellini M; Coltorti M
    Acta Diabetol Lat; 1986; 23(2):165-70. PubMed ID: 3529778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin effect due to increased secretion and decreased clearance of insulin in normal humans.
    Shuster LT; Go VL; Rizza RA; O'Brien PC; Service FJ
    Diabetes; 1988 Feb; 37(2):200-3. PubMed ID: 3292314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersecretion of proinsulin in thyrotoxicosis.
    Sestoft L; Heding LG
    Diabetologia; 1981 Aug; 21(2):103-7. PubMed ID: 7021283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
    Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
    Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
    Hartling SG; Garne S; Binder C; Heilmann C; Petersen W; Petersen KE; Koch C
    Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
    Horwitz DL; Starr JI; Mako ME; Blackard WG; Rubenstein AH
    J Clin Invest; 1975 Jun; 55(6):1278-83. PubMed ID: 1133173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
    Persson B; Hanson U; Hartling SG; Binder C
    Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
    Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2519-24. PubMed ID: 21593115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-peptide and proinsulin after oral glucose.
    Heding LG; Kasperska-Czyzykowa T
    Acta Med Scand Suppl; 1980; 639():33-6. PubMed ID: 6999837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.